Share
6,165 Posts.
lightbulb Created with Sketch. 2345
clock Created with Sketch.
04/02/21
21:26
Share
Originally posted by Galilee13:
↑
G med still has a requirement to lodge semi annual and annual reports with the SEC. not sure exactly how long after the 6 month period they have, but IMO it is 3 months. So in this regard we should see the annual report by the end of March. Don’t forget there is a delay of up to 90 days from when G Med bills the patient to when they receive the cash from insurance companies. So for me it’s all about patients seen in the short term. An extension of the chart showing how many patients seen per month until the end of Jan 21 would be very useful. As per my conversation with the CEO of Livecare, the prizma should be available on the Link+ platform any day now! More of an issue is what is happening with reimbursement rates. Late last year they were assumed to be going up and as such IRTC share price nearly doubled. Now, there is talk rates are coming down and in term we saw IRTC share price go from all time highs of $280 to a low of $130 in one day last week. And what about this OTC market. Both Brendan and Henry tell me the price is based on about 833m SOI (unconsolidated) So at last nights close we are at an market cap of $900m USD! IMO we should see the new F1 lodged around mid Feb and an IPO around mid March.
Expand
Do a search on " iRhythm, irtc, class action, 2021" Irtc sh price punished: Is this becoz mgt had known (zio and other irtc devices) reimbursement rates had dropped, since August2020 (to Jan 2021), but chose not to disclose info to the markets 4-5 mths ago? If so, then Irtc sp drop merely reflects mkt has lowered its fwd-looking/future revenues, and hence the MCap. Non-disclosure issue here is likely unique to irtc mgt. Dyor.
Last edited by
Glyco :
04/02/21